Baker Avenue Asset Management »

Regeneron Pharmaceuticals shares owned by Baker Avenue Asset Management

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Baker Avenue Asset Management from 13F filings

Historical chart of Baker Avenue Asset Management investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Baker Avenue Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Baker Avenue Asset Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $36k 44 822.95
2023-06-30 $31k 43 718.53
2023-03-31 $646k 786 821.67
2022-12-31 $491k 680 721.49

More positions owned by Baker Avenue Asset Management

Nvidia Corp Stock (NVDA)
Apple Stock (AAPL)
Powershares Qqq Tr Etf (QQQ)
Vanguard Small Cap Etf Etf (VB)
Microsoft Stock (MSFT)
Ishares Aggregate Bond Etf Etf (AGG)
Vanguard Total Bond Market Etf Etf (BND)
Spdr Portfolio Aggregate Bond Etf Etf (SPAB)
Dimensional Core Fixed Income Etf Etf (DFCF)
Ishares Msci Usa Quality Factor Etf Etf (QUAL)
Netflix Stock (NFLX)
Ishares Russell 1000 Growth Etf Etf (IWF)
Amazon.com Stock (AMZN)
Tesla Motors Stock (TSLA)
Ishares S&p 500 Index Etf (IVV)

View all positions for Baker Avenue Asset Management

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
Jpmorgan Chase & Co
Dodge & Cox
Wellington Management Company
Norges Bank Investment Management
Legal & General Group
Bank of America Corporation
Bank of New York Mellon
Amundi
Citadel Advisors
Alliancebernstein
T. Rowe Price Associates
Ubs Global Asset Management Americas
Charles Schwab Investment Management
Dimensional Fund Advisors

View all funds holding Regeneron Pharmaceuticals